Literature DB >> 2144199

Hepatitis B vaccine associated with erythema nodosum and polyarthritis.

S J Rogerson1, F J Nye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2144199      PMCID： PMC1663612          DOI： 10.1136/bmj.301.6747.345

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Erythema nodosum after Recombivax HB hepatitis B vaccine.

Authors:  P L Goolsby
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

2.  [Reactive arthritis following vaccination against hepatitis B].

Authors:  B Christau; P Helin
Journal:  Ugeskr Laeger       Date:  1987-07-06

3.  Erythema nodosum provoked by hepatitis B vaccine.

Authors:  C A Di Giusto; J D Bernhard
Journal:  Lancet       Date:  1986-11-01       Impact factor: 79.321
  3 in total
  5 in total

1.  Vaccination and rheumatoid arthritis.

Authors:  J Sibilia; J F Maillefert
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

2.  Can immunisation trigger rheumatoid arthritis?

Authors:  D P Symmons; K Chakravarty
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

3.  Reiter's syndrome and reactive arthritis in health care workers after vaccination.

Authors:  W Hassan; R Oldham
Journal:  BMJ       Date:  1994-07-09

4.  First Case of Erythema Nodosum Associated With Pfizer Vaccine.

Authors:  Mohammed H Aly; Abdulrahman A Alshehri; Abdelgaffar Mohammed; Abdulrahman M Almalki; Walaa A Ahmed; Alhanouf M Almuflihi; Atheer A Alwafi
Journal:  Cureus       Date:  2021-11-13

5.  Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

Authors:  Yimin Wu; Ruth D Ellis; Donna Shaffer; Erica Fontes; Elissa M Malkin; Siddhartha Mahanty; Michael P Fay; David Narum; Kelly Rausch; Aaron P Miles; Joan Aebig; Andrew Orcutt; Olga Muratova; Guanhong Song; Lynn Lambert; Daming Zhu; Kazutoyo Miura; Carole Long; Allan Saul; Louis H Miller; Anna P Durbin
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.